Regeneron

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Ingredients

Therapeutic: odronextamab for blood cancers

Follicular lymphoma (FL) is a slow-growing form of B cell non-Hodgkin lymphoma that is usually in the advanced stage by diagnosis. Median survival is typically 8–15 years, but none of the current therapy options are curative and most patients will relapse within 5 years
Pharmaceutical

Sanofi and Regeneron restructures immuno-oncology collaboration

The companies announce selection of two pipeline projects to continue collaboration while independently pursuing other programmes
Media

GlobalData publishes analysis of top 25 global pharma companies

The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights
Media

GlobalData names top 25 global pharma companies by market cap

The performance highlights of the top 25 publicly traded global pharma companies for the year 2017 have been confirmed in the latest research from GlobalData
Regulatory

Sanofi and Regeneron receive CHMP positive opinion for Kevzara

Kevzara (sarilumab) can be used to treat adult patients with moderately to severely active rheumatoid arthritis
Regulatory

Sanofi and Regeneron announce Marketing Authorisation Application for Dupixent (dupilumab) accepted for review by the EMA

Sanofi and Regeneron Pharmaceuticals, Inc.  today announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application (MAA) for Dupixent® (dupilumab) for the treatment of adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy
Research & Development

Curable initiates the International PSC Genome project in partnership with the Mayo Clinic

The Regeneron Genetics Center aims to sequence 5000 or more primary sclerosing cholangitis (PSC) patients, Mayo Clinic is contributing DNA samples from more than 1000 PSC patients
Subscribe now